M R Ranson|J H Scarffe - JoVE Visualize

Showing results (71-80 of 105) with videos related to

Pageof 11

Sort By:

British Journal of Cancer|June 1, 1988

A phase I and pharmacokinetic study of amphethinileD B Smith, C Ewen, J Mackintosh, et al.

Cancer Treatment Reports|September 1, 1987

Phase I clinical trial of methylene dimethane sulfonateD B Smith, B W Fox, N Thatcher, et al.

Bone Marrow Transplantation|August 24, 1999

Treatment outcome and prognostic factors for relapse after high-dose chemotherapy and peripheral blood stem cell rescue for patients with poor risk high grade non-Hodgkin's lymphomaS M Lee, W D Ryder, M J Clemons, et al.

British Journal of Cancer|February 9, 2005

Treatment of inoperable hepatocellular carcinoma with pegylated liposomal doxorubicin (PLD): results of a phase II studyJ W Valle, A Dangoor, J Beech, et al.

Journal of Clinical Pathology|February 4, 1999

PCR-ELISA for the early diagnosis of invasive pulmonary aspergillus infection in neutropenic patientsM E Jones, A J Fox, A J Barnes, et al.

British Journal of Cancer|May 1, 1980

Relationship between the pretreatment proliferative activity of marrow blast cells and prognosis of acute lymphoblastic leukaemia of childhoodJ H Scarffe, I M Hann, D I Evans, et al.

Bone Marrow Transplantation|April 10, 1999

Liposomal amphotericin (AmBisome) in the prophylaxis of fungal infections in neutropenic patients: a randomised, double-blind, placebo-controlled studyS M Kelsey, J M Goldman, S McCann, et al.

British Journal of Cancer|July 1, 1992

Recombinant human interleukin 4 (IL-4) given as daily subcutaneous injections--a phase I dose toxicity trialM H Gilleece, J H Scarffe, A Ghosh, et al.

The Journal of Infection|July 1, 1996

Fatal Candida tropicalis fungaemia in a leukaemic patient receiving fluconazole prophylaxisA J Barnes, A M Wardley, B A Oppenheim, et al.

Behring Institute Mitteilungen|August 1, 1988

Phase I/II study of recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for small cell lung cancerM Bronchud, J H Scarffe, N Thatcher, et al.

Pageof 11

Showing results (71-80 of 105) with videos related to

Sort By:

Pageof 11

British Journal of Cancer|June 1, 1988

A phase I and pharmacokinetic study of amphethinileD B Smith, C Ewen, J Mackintosh, et al.

Cancer Treatment Reports|September 1, 1987

Phase I clinical trial of methylene dimethane sulfonateD B Smith, B W Fox, N Thatcher, et al.

Bone Marrow Transplantation|August 24, 1999

Treatment outcome and prognostic factors for relapse after high-dose chemotherapy and peripheral blood stem cell rescue for patients with poor risk high grade non-Hodgkin's lymphomaS M Lee, W D Ryder, M J Clemons, et al.

British Journal of Cancer|February 9, 2005

Treatment of inoperable hepatocellular carcinoma with pegylated liposomal doxorubicin (PLD): results of a phase II studyJ W Valle, A Dangoor, J Beech, et al.

Journal of Clinical Pathology|February 4, 1999

PCR-ELISA for the early diagnosis of invasive pulmonary aspergillus infection in neutropenic patientsM E Jones, A J Fox, A J Barnes, et al.

British Journal of Cancer|May 1, 1980

Relationship between the pretreatment proliferative activity of marrow blast cells and prognosis of acute lymphoblastic leukaemia of childhoodJ H Scarffe, I M Hann, D I Evans, et al.

Bone Marrow Transplantation|April 10, 1999

Liposomal amphotericin (AmBisome) in the prophylaxis of fungal infections in neutropenic patients: a randomised, double-blind, placebo-controlled studyS M Kelsey, J M Goldman, S McCann, et al.

British Journal of Cancer|July 1, 1992

Recombinant human interleukin 4 (IL-4) given as daily subcutaneous injections--a phase I dose toxicity trialM H Gilleece, J H Scarffe, A Ghosh, et al.

The Journal of Infection|July 1, 1996

Fatal Candida tropicalis fungaemia in a leukaemic patient receiving fluconazole prophylaxisA J Barnes, A M Wardley, B A Oppenheim, et al.

Behring Institute Mitteilungen|August 1, 1988

Phase I/II study of recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for small cell lung cancerM Bronchud, J H Scarffe, N Thatcher, et al.

Pageof 11